ZA9110009B - Methylenebisphosphonic acid derivatives - Google Patents

Methylenebisphosphonic acid derivatives

Info

Publication number
ZA9110009B
ZA9110009B ZA9110009A ZA9110009A ZA9110009B ZA 9110009 B ZA9110009 B ZA 9110009B ZA 9110009 A ZA9110009 A ZA 9110009A ZA 9110009 A ZA9110009 A ZA 9110009A ZA 9110009 B ZA9110009 B ZA 9110009B
Authority
ZA
South Africa
Prior art keywords
opt
unsatd
substd
branched
alkyl
Prior art date
Application number
ZA9110009A
Other languages
English (en)
Inventor
Hannu Nikander
Nikander Hannu
Marjaana Heikkila-Hoikka
Heikkila-Hoikka Marjaana
Esko Pohjala
Pohjala Esko
Hannu Hanhijarvi
Hanhijarvi Hannu
Leena Lauren
Lauren Leena
Original Assignee
Huhtamaeki Yhthymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huhtamaeki Yhthymae Oy filed Critical Huhtamaeki Yhthymae Oy
Publication of ZA9110009B publication Critical patent/ZA9110009B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5537—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom the heteroring containing the structure -C(=O)-N-C(=O)- (both carbon atoms belong to the heteroring)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4025—Esters of poly(thio)phosphonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paints Or Removers (AREA)
  • Detergent Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
ZA9110009A 1990-12-20 1991-12-19 Methylenebisphosphonic acid derivatives ZA9110009B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI906294A FI89364C (fi) 1990-12-20 1990-12-20 Foerfarande foer framstaellning av nya, farmakologiskt anvaendbara metylenbisfosfonsyraderivat

Publications (1)

Publication Number Publication Date
ZA9110009B true ZA9110009B (en) 1992-09-30

Family

ID=8531619

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9110009A ZA9110009B (en) 1990-12-20 1991-12-19 Methylenebisphosphonic acid derivatives

Country Status (25)

Country Link
US (1) US5438048A (fr)
EP (1) EP0563096B1 (fr)
JP (1) JP3347324B2 (fr)
KR (1) KR100233986B1 (fr)
CN (1) CN1030609C (fr)
AT (1) ATE192451T1 (fr)
AU (1) AU665342B2 (fr)
CA (1) CA2098732C (fr)
CZ (1) CZ287453B6 (fr)
DE (1) DE69132163T2 (fr)
DK (1) DK0563096T3 (fr)
EE (1) EE02948B1 (fr)
ES (1) ES2147183T3 (fr)
FI (1) FI89364C (fr)
HU (1) HUT64546A (fr)
IE (1) IE914388A1 (fr)
IL (1) IL100338A (fr)
NO (1) NO301590B1 (fr)
NZ (1) NZ241041A (fr)
PL (1) PL169772B1 (fr)
RU (1) RU2079504C1 (fr)
SK (1) SK281788B6 (fr)
TW (1) TW203054B (fr)
WO (1) WO1992011267A1 (fr)
ZA (1) ZA9110009B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157027A (en) * 1991-05-13 1992-10-20 E. R. Squibb & Sons, Inc. Bisphosphonate squalene synthetase inhibitors and method
US5591730A (en) * 1993-10-12 1997-01-07 The Regents Of The University Of California Inhibition of urinary calculi growth
FI104901B (fi) 1997-10-20 2000-04-28 Leiras Oy Uudet metyleenibisfosfonihappojohdannaiset
AU6991400A (en) * 1999-08-03 2001-02-19 Amersham Plc Radiolabelled bisphosphonates and method
PL196485B1 (pl) * 2000-05-11 2008-01-31 Inst Farmaceutyczny Stała doustna kompozycja farmaceutyczna zawierająca aminową pochodną kwasu bisfosfonowego i sposób jej wytwarzania
PT1328277E (pt) * 2000-10-27 2007-05-31 Schering Ag Compostos bisfosfónicos para o fortalecimento do osso cortical.
DE60111574T2 (de) * 2001-01-23 2006-05-11 Gador S.A. Bisphosphonate enthaltende Zusammensetzungen zur Vorbeugung und/oder Heilung von metabolischen Knochenkrankheiten, Verfahren zu ihrer Herstellung und Benutzung dieser Zusammensetzungen
CA2443625A1 (fr) * 2001-05-02 2002-11-07 Novartis Ag Utilisation de bisphosphonates dans le traitement des metastases osseuses associees au cancer de la prostate
FR2837490B1 (fr) * 2002-03-21 2009-04-17 Univ Paris 13 Nouveaux derives de bisphosphonates, leurs preparations et utilisations
US20030036537A1 (en) * 2001-07-16 2003-02-20 Marc Lecouvey Bisphosphonate derivatives, their preparations and uses
ATE455121T1 (de) * 2001-07-16 2010-01-15 Univ Paris 13 Herstellungsverfahren von derivate von bisphosphonaten
US20080287400A1 (en) * 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US20080286359A1 (en) * 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
WO2010035664A1 (fr) * 2008-09-24 2010-04-01 田辺三菱製薬株式会社 Procédé de production d'un dérivé d'acide bisphosphonique
CN107011380A (zh) * 2016-01-28 2017-08-04 臧伟 一种二膦酸衍生物及含二膦酸衍生物的组合物治疗骨折的应用
TWI730039B (zh) * 2016-01-29 2021-06-11 日商富士藥品股份有限公司 新穎雙膦酸化合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3303139A (en) * 1962-01-27 1967-02-07 Henkel & Cie Gmbh Aminophosphonic acids and their derivatives as complex formers for metal ions
DE1202441B (de) * 1963-03-02 1965-10-07 Therachemie Chem Therapeut Mittel zur Verminderung der Schaedigung von Haaren beim Bleichen und Faerben
DE1617118C3 (de) * 1966-08-26 1975-04-03 Henkel & Cie Gmbh, 4000 Duesseldorf Verfahren zur Reinigung von etikettierten starren Gegenständen
US3962318A (en) * 1970-04-13 1976-06-08 Monsanto Company Substituted ethane diphosphonic acids and salts and esters thereof
US3957858A (en) * 1970-04-13 1976-05-18 Monsanto Company Substituted ethane diphosphonic acids and salts and esters thereof
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
CH555894A (fr) * 1972-08-10 1974-11-15 Oxy Metal Industries Corp Utilisation de derives organophosphores dans les bains sulfitiques pour l'electrodeposition de l'or et des alliages d'or.
US4113861A (en) * 1977-05-02 1978-09-12 The Procter & Gamble Company Phosphonate pharmaceutical composition
GB2043072B (en) * 1979-02-13 1983-11-23 Symphar Sa Diphosphonate compounds
US4634691A (en) * 1980-10-07 1987-01-06 The Procter & Gamble Company Method for inhibiting tumor metastasis
DE3225469A1 (de) * 1982-07-05 1984-01-05 Schering AG, 1000 Berlin und 4709 Bergkamen Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate
US4818774A (en) * 1986-03-10 1989-04-04 Occidental Chemical Corporation Organophosphorus compounds
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
SK62993A3 (en) 1993-12-08
KR930703334A (ko) 1993-11-29
NO932254D0 (no) 1993-06-18
SK281788B6 (sk) 2001-07-10
JPH06504045A (ja) 1994-05-12
US5438048A (en) 1995-08-01
FI906294A0 (fi) 1990-12-20
DE69132163T2 (de) 2001-01-11
EE02948B1 (et) 1996-12-16
NO932254L (no) 1993-08-19
PL169772B1 (pl) 1996-08-30
NO301590B1 (no) 1997-11-17
DK0563096T3 (da) 2000-09-25
CN1030609C (zh) 1996-01-03
FI906294A (fi) 1992-06-21
ATE192451T1 (de) 2000-05-15
RU2079504C1 (ru) 1997-05-20
TW203054B (fr) 1993-04-01
CN1062532A (zh) 1992-07-08
WO1992011267A1 (fr) 1992-07-09
FI89364C (fi) 1993-09-27
FI89364B (fi) 1993-06-15
JP3347324B2 (ja) 2002-11-20
CZ287453B6 (cs) 2000-11-15
AU665342B2 (en) 1996-01-04
NZ241041A (en) 1994-09-27
CA2098732A1 (fr) 1992-06-21
EP0563096B1 (fr) 2000-05-03
IE914388A1 (en) 1992-07-01
KR100233986B1 (ko) 1999-12-15
IL100338A0 (en) 1992-09-06
AU9074991A (en) 1992-07-22
HU9301779D0 (en) 1993-09-28
CZ119893A3 (en) 1994-02-16
HUT64546A (en) 1994-01-28
DE69132163D1 (de) 2000-06-08
ES2147183T3 (es) 2000-09-01
EP0563096A1 (fr) 1993-10-06
CA2098732C (fr) 2002-03-05
IL100338A (en) 1998-01-04

Similar Documents

Publication Publication Date Title
IL100338A0 (en) Methylenebisphosphonic acid derivatives
IL100337A0 (en) Methylenebisphosphonic acid derivatives
ES2183526T3 (es) Derivados de acidos grasos de acidos biliares y derivados del acido biliar.
IL104090A (en) Phosphonosuccinic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing these compounds
DE69130231D1 (de) Neue methylenbisphosphonsaürederivate
IE801441L (en) Triiod0isophthalic acids, x-ray contrast agents
ATE128139T1 (de) Neue methylenbisphosphonsäurederivate.
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
FR2499076B1 (fr)
SE8008189L (sv) Foreningar med antiallergisk och antiulceros verkan, nemligen 1-oxo-1h-tiazolo(3,2-a)pyrimidin-2-karboxamider och mellanprodukter for dessa
FI950259A0 (fi) Uudet, asykliset, amidiiniryhmiä sisältävät difosfonihappojohdannaiset, menetelmä niiden valmistamiseksi ja näitä yhdisteitä sisältävät lääkeaineet
AU3873189A (en) 5-substituted uridine derivatives and intermediates for their preparation
ATE135571T1 (de) Organogermaniumderivate enthaltende zubereitungen zur therapeutischen verwendung
IT1220977B (it) Pirazolo (1,2-a) (1,2,4) benzotriazine
FR2453161A1 (fr) Procede de preparation de derives d'acide thiazolylacetique et nouveaux produits ainsi obtenus
GB2022583A (en) New ionic polyiodo benzene derivatives useful as X-ray contrast media